AWG
LENZ

Alpha Wave Global’s LENZ Therapeutics LENZ Stock Holding History

Alpha Wave Global’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Hold
3,612,211
– – 0.33% 10
2026
Q1 		$33.1M Hold
3,612,211
– – 4.18% 4
2025
Q4 		$57.8M Hold
3,612,211
– – 7.09% 3
2025
Q3 		$168M Hold
3,612,211
– – 17.04% 2
2025
Q2 		$106M Hold
3,612,211
– – 11.41% 2
2025
Q1 		$92.9M Hold
3,612,211
– – 41.37% 1
2024
Q4 		$104M Hold
3,612,211
– – 47.85% 1
2024
Q3 		$85.8M Hold
3,612,211
– – 26.46% 1
2024
Q2 		$62.5M Hold
3,612,211
– – 20.46% 1
2024
Q1 		$80.7M Buy
+3,612,211
New +$75.1M 24% 1

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Alpha Wave Global's LENZ Position: Q2 2026 in Review

Alpha Wave Global held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 3,612,211 shares worth $20.5M. The position accounts for 0.33% of the portfolio, ranked #10.

Alpha Wave Global first reported a position in LENZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $168M in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Alpha Wave Global held 3,612,211 shares of LENZ Therapeutics worth $20.5M as of Q2 2026.
  • Alpha Wave Global left its LENZ Therapeutics share count unchanged in Q2 2026.
  • LENZ Therapeutics made up 0.33% of Alpha Wave Global's portfolio in Q2 2026, its #10 holding.
  • Alpha Wave Global first reported a position in LENZ Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Alpha Wave Global's LENZ Therapeutics position peaked at $168M in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Alpha Wave Global's 13F filing for Q2 2026, filed 13 Aug 2026.